Fund Holdings — Logos Global Management LP

Total Portfolio Value:
$854.65M
Total Bought:
$329.13M
Total Sold:
$340.28M
Net Transaction:
-$11.15M
Notable People:
Logos Global Management Gp Llc, Arsani Hany William, Graham Gordon Walmsley
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
IDEAYA Biosciences, Inc.(IDYA)2,100,0003,000,000+900,000$66.53M$77.10M9.02%+$10.57M
Janux Therapeutics, Inc.(JANX)1,000,0001,250,000+250,000$45.43M$66.92M7.83%+$21.50M
Revolution Medicines, Inc.(RVMD)1,200,0001,450,000+250,000$54.42M$63.42M7.42%+$9.00M
Cytokinetics, Incorporated(CYTK)400,000900,000+500,000$21.12M$42.34M4.95%+$21.22M
Vera Therapeutics, Inc.CL A(VERA)500,000875,000+375,000$22.10M$37.00M4.33%+$14.90M
BioNTech SEADS(BNTX)0300,000+300,000$0$34.19M4.00%+$34.19M
Merus N V575,000750,000+175,000$28.73M$31.54M3.69%+$2.81M
Erasca, Inc.(ERAS)10,900,00012,500,000+1,600,000$29.76M$31.38M3.67%+$1.62M
Insmed Incorporated(INSM)0450,000+450,000$0$31.07M3.64%+$31.07M
Ocular Therapeutix, Inc.(OCUL)3,500,0003,500,0000$30.45M$29.89M3.50%-$560.0K
Neurocrine Biosciences, Inc.(NBIX)0200,000+200,000$0$27.30M3.19%+$27.30M
Design Therapeutics, Inc.(DSGN)4,217,6274,217,6270$22.69M$26.02M3.04%+$3.33M
Vaxcyte, Inc.(PCVX)300,000300,0000$34.28M$24.56M2.87%-$9.72M
Akero Therapeutics Inc800,000800,0000$22.95M$22.26M2.60%-$696.0K
Jazz Pharmaceuticals plcSHS USD(JAZZ)0175,000+175,000$0$21.55M2.52%+$21.55M
Structure Therapeutics IncADS1,250,000700,000-550,000$54.86M$18.98M2.22%-$35.88M
Olema Pharmaceuticals, Inc.(OLMA)3,208,8753,208,8750$38.31M$18.71M2.19%-$19.61M
Blueprint Medicines Corp0200,000+200,000$0$17.44M2.04%+$17.44M
Travere Therapeutics, Inc.(TVTX)1,100,0001,000,000-100,000$15.39M$17.42M2.04%+$2.03M
Apellis Pharmaceuticals Inc
COM
0500,000+500,000$0$15.96M1.87%+$15.96M
Soleno Therapeutics Inc0350,000+350,000$0$15.73M1.84%+$15.73M
Alkermes plcSHS(ALKS)0500,000+500,000$0$14.38M1.68%+$14.38M
Apogee Therapeutics Inc0300,000+300,000$0$13.59M1.59%+$13.59M
Arvinas, Inc.(ARVN)400,000700,000+300,000$9.85M$13.42M1.57%+$3.57M
Annexon, Inc.(ANNX)2,600,0002,550,000-50,000$15.39M$13.08M1.53%-$2.31M
Disc Medicine, Inc.(IRON)935,000200,000-735,000$45.95M$12.68M1.48%-$33.27M
Spyre Therapeutics, Inc.(SYRE)200,000500,000+300,000$5.88M$11.64M1.36%+$5.76M
Edgewise Therapeutics, Inc.(EWTX)450,000400,000-50,000$12.01M$10.68M1.25%-$1.33M
Dyne Therapeutics, Inc.(DYN)160,000450,000+290,000$5.75M$10.60M1.24%+$4.85M
Pliant Therapeutics, Inc.(PLRX)0750,000+750,000$0$9.88M1.16%+$9.88M
Bright Minds Biosciences Inc.(DRUG)0245,000+245,000$0$8.82M1.03%+$8.82M
Y-Mabs Therapeutics Inc800,0001,000,000+200,000$10.52M$7.83M0.92%-$2.69M
Immunovant, Inc.(IMVT)1,100,000300,000-800,000$31.36M$7.43M0.87%-$23.93M
Geron Corporation(GERN)02,000,000+2,000,000$0$7.08M0.83%+$7.08M
Aclaris Therapeutics, Inc.(ACRS)02,222,222+2,222,222$0$5.51M0.64%+$5.51M
Trevi Therapeutics, Inc.(TRVI)2,750,0001,250,000-1,500,000$9.19M$5.15M0.60%-$4.04M
Astria Therapeutics Inc500,000500,0000$5.50M$4.47M0.52%-$1.03M
Unicycive Therapeutics Inc5,078,9275,078,9270$2.07M$4.03M0.47%+$1.96M
Aerovate Therapeutics Inc01,400,000+1,400,000$0$3.71M0.43%+$3.71M
Rapport Therapeutics, Inc.(RAPP)208,910208,9100$4.06M$3.71M0.43%-$358.5K
Atyr Pharma Inc2,000,0001,000,000-1,000,000$3.52M$3.62M0.42%+$100.0K
Allakos Inc2,900,0002,900,0000$1.89M$3.51M0.41%+$1.61M
Enliven Therapeutics Inc495,000140,000-355,000$12.64M$3.15M0.37%-$9.49M
Septerna, Inc.(SEPN)0134,202+134,202$0$3.07M0.36%+$3.07M
Artiva Biotherapeutics, Inc.(ARTV)145,089145,0890$2.13M$1.46M0.17%-$667.0K
Glycomimetics Inc05,400,000+5,400,000$0$1.34M0.16%+$1.34M
Nuvation Bio Inc.W EXP 02 10 202(NUVB)066,666+66,666$0$15.3K0.00%+$15.3K
Adverum Biotechnologies Inc416,6660-416,666$2.92M$0—-$2.92M
Avalo Therapeutics, Inc.(AVTX)539,0790-539,079$5.12M$0—-$5.12M
Beam Therapeutics Inc.(BEAM)500,0000-500,000$12.25M$0—-$12.25M
Bicara Therapeutics Inc800,0000-800,000$20.38M$0—-$20.38M
Bicycle Therapeutics PlcADS500,0000-500,000$11.31M$0—-$11.31M
Boundless Bio, Inc.(BOLD)58,9030-58,903$204.4K$0—-$204.4K
Celldex Therapeutics, Inc.(CLDX)900,0000-900,000$30.59M$0—-$30.59M
Cogent Biosciences, Inc.(COGT)2,000,0000-2,000,000$21.60M$0—-$21.60M
COMPASS Pathways plcADS(CMPS)1,159,0300-1,159,030$7.30M$0—-$7.30M
Cybin D/B/A Helus Pharma(HELP)600,0000-600,000$5.33M$0—-$5.33M
Engene Holdings Inc
COM
800,0000-800,000$5.28M$0—-$5.28M
Lakefront Biotherapeutics NVADR(LKFT)800,0000-800,000$23.03M$0—-$23.03M
Io Biotech Inc493,8270-493,827$518.5K$0—-$518.5K
Ionis Pharmaceuticals, Inc.(IONS)750,0000-750,000$30.05M$0—-$30.05M
Lineage Cell Therapeutics, Inc.(LCTX)5,000,0000-5,000,000$4.53M$0—-$4.53M
Neumora Therapeutics, Inc.(NMRA)100,0000-100,000$1.32M$0—-$1.32M
Nextcure Inc2,500,0000-2,500,000$3.42M$0—-$3.42M
Nuvalent Inc75,0000-75,000$7.67M$0—-$7.67M
Oruka Therapeutics, Inc.(ORKA)257,3300-257,330$6.31M$0—-$6.31M
Rocket Pharmaceuticals, Inc.(RCKT)325,0000-325,000$6.00M$0—-$6.00M
Sarepta Therapeutics, Inc.(SRPT)150,0000-150,000$18.73M$0—-$18.73M
Silence Therapeutics plcADS(SLN)200,0000-200,000$3.64M$0—-$3.64M
Skye Bioscience, Inc.(SKYE)100,0000-100,000$391.0K$0—-$391.0K
Page 1 of 1
Logos Global Management LP — 13F Holdings — Q4 2024 | TickerTrail